Notice of Removal: Quantitative ultrasound spectroscopy to differentiate between hepatocellular carcinoma and at-risk liver parenchyma

Early detection of hepatocellular carcinoma (HCC) is critically needed to improve patient survival. Ultrasound is the first-line technology to screen patients at increased risk but has low sensitivity and specify in particular in hepatic cirrhosis. Quantitative ultrasound spectroscopy (QUS) is a promising tool that may increase diagnostic accuracy of ultrasound by enabling quantitative assessment and computerized screening. This study aimed to perform a clinical assessment of QUS parameters for differentiating HCC lesion tissue from liver parenchyma.